EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Biomarcadores emergentes en diagnóstico y seguimiento de esclerosis múltiple

Nayely Micaela Yaguana Retete, Jimmy Fernando Yaguana Torres, Victor José Barrera Avendaño, George William Rodríguez Correa, Dana Milena Mosquera Calderón

Salud Medicina e Innovación Journal · 05.08.2026 · 4 (3) · 301-318

DOI: 10.70577/swdqp234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Salud Medicina e Innovación Journal, online erschienen am 05.08.2026. Verfasst von Nayely Micaela Yaguana Retete und 4 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis is a chronic neuroinflammatory and neurodegenerative disease whose diagnosis and monitoring remain significant clinical challenges. This review aimed to analyze the available scientific evidence on emerging biomarkers used for the diagnosis and monitoring of multiple sclerosis, identifying their main clinical applications, advantages, limitations, and future perspectives. A literature review was conducted following the PRISMA 2020 guidelines through searches in PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect, and SpringerLink. The available evidence indicate that serum neurofilament light chain and glial fibrillary acidic protein are currently the most promising biomarkers for assessing neuroaxonal damage, inflammatory activity, and disease progression. In addition, kappa free light chains and omics-based technologies demonstrate increasing potential to improve precision diagnosis and patient stratification. It is concluded that integrating biological biomarkers with neuroimaging and artificial intelligence will support the implementation of precision medicine strategies and optimize individualized clinical management of patients with multiple sclerosis.

Zitieren

APA

Retete, N. M. Y., Torres, J. F. Y., Avendaño, V. J. B., Correa, G. W. R., & Calderón, D. M. M. (2026). Biomarcadores emergentes en diagnóstico y seguimiento de esclerosis múltiple. Salud Medicina e Innovación Journal, 4(3), 301-318. https://doi.org/10.70577/swdqp234

Vancouver

Retete NMY, Torres JFY, Avendaño VJB, Correa GWR, Calderón DMM. Biomarcadores emergentes en diagnóstico y seguimiento de esclerosis múltiple. Salud Medicina e Innovación Journal. 2026;4(3):301-318. doi:10.70577/swdqp234

BibTeX
@article{Retete2026,
  author = {Retete, Nayely Micaela Yaguana and Torres, Jimmy Fernando Yaguana and Avendaño, Victor José Barrera and Correa, George William Rodríguez and Calderón, Dana Milena Mosquera},
  title = {Biomarcadores emergentes en diagnóstico y seguimiento de esclerosis múltiple},
  journal = {Salud Medicina e Innovación Journal},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {301--318},
  doi = {10.70577/swdqp234}
}
Kostenlos starten →